Skip to main content
. 2021 Jan 6;50(7):1419–1425. doi: 10.1007/s00256-020-03695-3

Table 1.

Serum gadolinium (Gd) concentrations at various time points following intra-articular injection

ng Gd/ml serum, (median and range)
Group 0 h 1 h 3 h 6 h 24 h 72 h
Saline

0.01

(0.00–0.09)

0.02

(0.00–0.04)

0.02

(0.00–0.02)

0.09

(0.00–0.12)

0.67

(0.00–1.62)

0.59

(0.38–3.41)

High-dose gadodiamide

0.09

(0.03–0.58)

34,696

(32742–48,306)

1158

(1075–2555)

78.76

(36.78–120)

25.26

(16.54–27.51)

14.43

(7.69–15.75)

High-dose gadobutrol

0.01

(0.01–0.05)

17,621

(14354–46,869)

1723

(278–2000)

44.92

(24.26–65.55)

16.5

(10.32–19.36)

6.67

(4.53–9.38)

Low-dose gadodiamide

0.49

(0.02–1.13)

566

(374–595)

15.59

(13.03–16.65)

1.66

(1.62–1.86)

0.51

(0.49–0.56)

0.19

(0.17–0.21)

Low dose gadobutrol

0.55

(0.09–1.03)

883

(778–898)

25.35

(21.08–32.71)

1.34

(1.15–2.03)

0.61

(0.41–0.87)

0.31

(0.21–0.34)